It was suggested that both the excessive activation and the suppression of TLR2/4 might be involved in COPD pathogenesis, and that modulation of TLR2 and/or TLR4 expression might become relevant in the future COPD therapeutic regime [18, 19]. The gene discussed is TLR4; the disease is chronic obstructive pulmonary disease.